Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01747447 · ClinicalTrials.gov registry record · NA
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 771
- Enrollment target
NCT01747447 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 771 participants.
The verdict
NCT01747447, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 771 participants
- Enrollment target
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among a sub-cohort of 771 participants in VITAL and will test the efficacy and safety of high-dose vitamin D supplementation vs. placebo on skeletal health and body composition.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DIETARY_SUPPLEMENT omega-3 fatty acids (fish oil)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 771 participants |
| Start Date | 2012-08 |
| Est. Completion | 2023-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01747447
The ClinicalTrials.gov registry entry for NCT01747447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 771 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin D3 is the first listed.
NCT01747447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01747447 about?
NCT01747447 is a clinical study titled "VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and strok...
What is the current status of trial NCT01747447?
This trial is currently completed. It is a NA study. The enrollment target is 771 participants. The study started on 2012-08. Estimated completion is 2023-08-02.
What interventions are being tested in trial NCT01747447?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), omega-3 fatty acids (fish oil) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01747447?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.